Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Celiac disease associated SNP rs17810546 is located in a gene silencing region.

Zwiers A, van Wanrooij RLJ, Dieckman T, Nijeboer P, Kraal G, Bouma G.

Gene. 2019 Nov 11:144165. doi: 10.1016/j.gene.2019.144165. [Epub ahead of print]

PMID:
31726085
2.

Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease: Consequences for follow-up: Celiac disease, lymphoma and GI carcinoma.

van Gils T, Nijeboer P, Overbeek LI, Hauptmann M, Castelijn DA, Bouma G, Mulder CJ, van Leeuwen FE, de Jong D.

United European Gastroenterol J. 2018 Dec;6(10):1485-1495. doi: 10.1177/2050640618800540. Epub 2018 Sep 12.

3.

A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease.

Hrdlickova B, Mulder CJ, Malamut G, Meresse B, Platteel M, Kamatani Y, Ricaño-Ponce I, van Wanrooij RLJ, Zorro MM, Jan Bonder M, Gutierrez-Achury J, Cellier C, Zhernakova A, Nijeboer P, Galan P, Withoff S, Lathrop M, Bouma G, Xavier RJ, Jabri B, Bensussan NC, Wijmenga C, Kumar V.

Eur J Gastroenterol Hepatol. 2018 Aug;30(8):828-837. doi: 10.1097/MEG.0000000000001168.

4.

Gamma-Delta T Lymphocytes in the Diagnostic Approach of Coeliac Disease.

Nijeboer P, van Gils T, Reijm M, Ooijevaar R, Lissenberg-Witte BI, Bontkes HJ, Mulder CJJ, Bouma G.

J Clin Gastroenterol. 2019 May/Jun;53(5):e208-e213. doi: 10.1097/MCG.0000000000001060.

PMID:
29782465
5.

Splenic volume differentiates complicated and non-complicated celiac disease.

van Gils T, Nijeboer P, van Waesberghe JHT, Coupé VM, Janssen K, Zegers JA, Nurmohamed SA, Kraal G, Jiskoot SC, Bouma G, Mulder CJ.

United European Gastroenterol J. 2017 Apr;5(3):374-379. doi: 10.1177/2050640616663571. Epub 2016 Aug 17.

6.

Prevalence and Characterization of Self-Reported Gluten Sensitivity in The Netherlands.

van Gils T, Nijeboer P, IJssennagger CE, Sanders DS, Mulder CJ, Bouma G.

Nutrients. 2016 Nov 8;8(11). pii: E714.

7.

High myeloid-derived suppressor cell frequencies in the duodenum are associated with enteropathy associated T-cell lymphoma and its precursor lesions.

Bontkes HJ, Jordanova ES, Nijeboer P, Neefjes-Borst EA, Cillessen SAGM, Hayat A, Mulder CJ, Bouma G, von Blomberg BM, de Gruijl TD.

Br J Haematol. 2017 Sep;178(6):988-991. doi: 10.1111/bjh.14186. Epub 2016 Jun 24. No abstract available.

PMID:
27341082
8.

Surgery in (pre)malignant celiac disease.

van de Water JM, Nijeboer P, de Baaij LR, Zegers J, Bouma G, Visser OJ, van der Peet DL, Mulder CJ, Meijerink WJ.

World J Gastroenterol. 2015 Nov 21;21(43):12403-9. doi: 10.3748/wjg.v21.i43.12403.

9.

Mechanisms and management of refractory coeliac disease.

van Gils T, Nijeboer P, van Wanrooij RL, Bouma G, Mulder CJ.

Nat Rev Gastroenterol Hepatol. 2015 Oct;12(10):572-9. doi: 10.1038/nrgastro.2015.155. Epub 2015 Sep 8. Review.

PMID:
26347156
10.

Serum intestinal-fatty acid binding protein as a biomarker for refractory celiac disease.

Gross S, Adriaanse MP, Nijeboer P, Tack GJ, van Hoogstraten IM, Bouma G, Mulder CJ, von Blomberg BM, Vreugdenhil AC, Bontkes HJ.

J Gastrointestin Liver Dis. 2015 Jun;24(2):258-9. No abstract available.

11.

Refractory celiac disease and EATL patients show severe malnutrition and malabsorption at diagnosis.

Wierdsma NJ, Nijeboer P, de van der Schueren MA, Berkenpas M, van Bodegraven AA, Mulder CJ.

Clin Nutr. 2016 Jun;35(3):685-91. doi: 10.1016/j.clnu.2015.04.014. Epub 2015 Apr 30.

12.

Therapy in RCDII: Rationale for Combination Strategies?

Nijeboer P, Malamut G, Bouma G, Cerf-Bensussan N, Koning F, van Bergen J, Cellier C, Mulder CJ.

Dig Dis. 2015;33(2):227-30. doi: 10.1159/000381076. Epub 2015 Apr 22. Review.

PMID:
25925927
13.

Treatment response in enteropathy associated T-cell lymphoma; survival in a large multicenter cohort.

Nijeboer P, de Baaij LR, Visser O, Witte BI, Cillessen SA, Mulder CJ, Bouma G.

Am J Hematol. 2015 Jun;90(6):493-8. doi: 10.1002/ajh.23992. Epub 2015 May 10.

14.

Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases.

Al-toma A, Nijeboer P, Bouma G, Visser O, Mulder CJ.

World J Gastroenterol. 2014 Dec 14;20(46):17368-75. doi: 10.3748/wjg.v20.i46.17368. Review.

15.

[Diarrhoea and malabsorption due to olmesartan use].

van Beurden YH, Nijeboer P, Janssen J, Verbeek WH, Mulder CJ.

Ned Tijdschr Geneeskd. 2014;158:A7370. Dutch.

PMID:
24780574
16.

Non-celiac gluten sensitivity. Is it in the gluten or the grain?

Nijeboer P, Bontkes HJ, Mulder CJ, Bouma G.

J Gastrointestin Liver Dis. 2013 Dec;22(4):435-40. Review.

17.

Update on the diagnosis and management of refractory coeliac disease.

Nijeboer P, van Wanrooij RL, Tack GJ, Mulder CJ, Bouma G.

Gastroenterol Res Pract. 2013;2013:518483. doi: 10.1155/2013/518483. Epub 2013 May 9.

18.

[Non-coeliac gluten sensitivity: hype, or new epidemic?].

Nijeboer P, Mulder C, Bouma G.

Ned Tijdschr Geneeskd. 2013;157(21):A6168. Review. Dutch.

PMID:
23693012
19.

Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac disease.

Gross S, van Wanrooij RL, Nijeboer P, Gelderman KA, Cillessen SA, Meijer GA, Mulder CJ, Bouma G, von Blomberg BM, Bontkes HJ.

Mediators Inflamm. 2013;2013:939047. doi: 10.1155/2013/939047. Epub 2013 Apr 15.

Supplemental Content

Loading ...
Support Center